Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bio
3
×
startups
tc
theranos
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
biogen
biome
biotech
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
celgene
centers for medicare and medicaid services
cervical cancer
clinical study
clinical trial
commissioner
crispr
crispr therapeutics
cybersecurity
democrats
detection
detroit blog main
detroit top stories
digital health
diversity
donald trump
edison blood test
What
bio
3
×
blood
read
startup
tech
theranos
troubled
years
allogene
analysis
beleaguered
cancer
centers
chief
claims
cms
company
coo
crispr
currently
devices
diagnostics
diversity
doctors
edison
federal
future
hot
immunotherapy
investigation
investors
ipo
journal
juno
making
medicaid
medical
medicare
million
misleading
Language
Current search:
bio
×
bio
×
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com
8 years ago
Theranos reportedly voids two years of reports from its Edison blood-testing devices
@techcrunch.com
8 years ago
Theranos’ COO retires as the troubled bio-tech startup overhauls its organizational structure
